Search for: "Genzyme Corp."
Results 1 - 20
of 76
Sorted by Relevance
|
Sort by Date
31 Jan 2011, 10:38 am
So says Reuters: U.S. biotech company Genzyme Corp and French drugmaker Sanofi-Aventis SA have reached an agreement in principle on the outlines of a merger deal, three sources familiar with the situation said on Monday. [read post]
17 Apr 2007, 1:18 am
The case is Genzyme Corp. v. [read post]
25 May 2010, 12:00 pm
Genzyme Corp. [read post]
9 Sep 2013, 12:29 pm
Genzyme Corp., Case No. 2:12CV587DAK (D. [read post]
1 Jan 2014, 8:26 am
On December 20, the Department of Justice announced that Genzyme Corp., the manufacturer of an adhesive barrier, had agreed to pay $22.28 million to resolve allegations that it marketed its device for an off-label use, as a “slurry” in minimally-invasive surgeries. [read post]
13 May 2010, 4:48 pm
Drug maker Genzyme Corp. will pay the Food and Drug Administration $175 million to settle a consent decree, a serious enforcement action. [read post]
5 Jul 2010, 9:47 pm
Genzyme Corp. v. [read post]
24 Aug 2011, 4:17 am
Genzyme Corp. v. [read post]
4 Sep 2015, 6:02 pm
On September 3, the Department of Justice announced that Genzyme Corp., which paid $22.28 million in January 2014 to settle civil allegations brought by two whistleblowers that the company marketed its Seprafilm adhesion barrier for off-label purposes. [read post]
26 Jul 2016, 8:45 pm
Genzyme Corp. et al. v. [read post]
15 Nov 2009, 4:29 pm
A federal district court has ruled in Genzyme Corp. v. [read post]
7 Jun 2014, 5:00 am
On Thursday, the First Circuit handed down its opinion in In re Genzyme Corp. [read post]
7 Apr 2015, 2:13 am
Genzyme Corp., 2015 WL 1333271. [read post]
21 Aug 2008, 3:26 pm
Genzyme Corp., N.D. [read post]
12 Mar 2010, 6:41 am
Genzyme Corp., No. 08-C-593, slip op. [read post]
27 Jul 2012, 10:09 am
Genzyme Corp., C.A. [read post]
4 Oct 2009, 4:56 pm
Genzyme Corp. v. [read post]
6 Apr 2009, 7:10 pm
Genzyme Corp. v. [read post]
18 Oct 2009, 9:17 pm
Genzyme Corp. 1:09-cv-00768; filed October 14, 2009 in the District Court of Delaware Infringement of U.S. [read post]
4 Mar 2015, 1:32 pm
Last week, MBBP’s Scott Bleier attended a panel discussion hosted by the Johnson & Johnson Boston Innovation Center, which featured three corporate venture capitalists from Sanofi-Genzyme Bioventures, Boehringer Ingelheim Venture USA Inc. and Johnson & Johnson Development Corp. [read post]
